Simulated oxygen and glucose gradients as a prerequisite for predicting industrial scale performance a priori.

Transferring bioprocesses from lab to industrial scale without loss of performance is key for the successful implementation of novel production approaches. Because mixing and mass transfer is usually hampered in large scale, cells experience heterogeneities eventually causing deteriorated yields, that is, reduced titers, productivities, and sugar-to-product conversions. Accordingly, reliable and easy-to-implement tools for a priori prediction of large-scale performance based on dry and wet-lab tests are heavily needed.

Lagrangian Trajectories to Predict the Formation of Population Heterogeneity in Large-Scale Bioreactors.

Successful scale-up of bioprocesses requires that laboratory-scale performance is equally achieved during large-scale production to meet economic constraints. In industry, heuristic approaches are often applied, making use of physical scale-up criteria that do not consider cellular needs or properties. As a consequence, large-scale productivities, conversion yields, or product purities are often deteriorated, which may prevent economic success.

Ubiquitin orchestrates proteasome dynamics between proliferation and quiescence in yeast.

Proteasomes are essential for protein degradation in proliferating cells. Little is known about proteasome functions in quiescent cells. In nondividing yeast, a eukaryotic model of quiescence, proteasomes are depleted from the nucleus and accumulate in motile cytosolic granules termed proteasome storage granules (PSGs).

Experimentally Validated Model Enables Debottlenecking of in Vitro Protein Synthesis and Identifies a Control Shift under in Vivo Conditions.

Cell-free (in vitro) protein synthesis (CFPS) systems provide a versatile tool that can be used to investigate different aspects of the transcription-translation machinery by reducing cells to the basic functions of protein formation. Recent improvements in reaction stability and lysate preparation offer the potential to expand the scope of in vitro biosynthesis from a research tool to a multifunctional and versatile platform for protein production and synthetic biology. To date, even the best-performing CFPS systems are drastically slower than in vivo references.